A Mutation Found in the Promoter Region of the Human Survivin Gene Is Correlated to Overexpression of Survivin in Cancer Cells
- 1 September 2004
- journal article
- research article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 23 (9) , 527-537
- https://doi.org/10.1089/dna.2004.23.527
Abstract
Survivin, a unique antiapoptotic factor, plays an important role in cell cycle regulation. Numerous clinical studies have shown that survivin is markedly overexpressed in most common types of cancer, suggesting that transcriptional deregulation is a major mechanism involved in aberrant expression of survivin in cancers. In this study, we have identified several polymorphisms in the survivin gene promoter. One of these polymorphisms is located at CDE/CHR repressor elements, and appears to be a common mutation with high frequency among cancer cell lines compared to normal cell line controls. The presence of the mutation was correlated in these cell lines with increased survivin expression at the both mRNA and protein levels. Furthermore, gel mobility shift analysis and transcriptional analysis showed the mutation changed cell cycle-dependent transcription by modifying the binding motif of the CDE/CHR repressor. These results indicate that the high level of survivin in some cancers is, at least in part, due to a genetic defect in the promoter region of the human survivin gene, which causes derepression of survivin transcription apparently due to the mutated CDE/CHR repressor binding motifs.Keywords
This publication has 37 references indexed in Scilit:
- Direct Interaction between Survivin and Smac/DIABLO Is Essential for the Anti-apoptotic Activity of Survivin during Taxol-induced ApoptosisJournal of Biological Chemistry, 2003
- Overexpression of B-type cyclins alters chromosomal segregationOncogene, 2002
- Survivin promotes cell proliferation in human hepatocellular carcinomaHepatology, 2000
- Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell deathOncogene, 2000
- Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human MelanomaJournal of Investigative Dermatology, 1999
- CHF: a novel factor binding to cyclin A CHR corepressor elementOncogene, 1999
- Binding of Mammalian Ribosomal Protein Complex P0·P1·P2 and Protein L12 to the GTPase-associated Domain of 28 S Ribosomal RNA and Effect on the Accessibility to Anti-28 S RNA AutoantibodyJournal of Biological Chemistry, 1997
- G1 phase progression: Cycling on cueCell, 1994
- Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycleCell, 1994
- Universal control mechanism regulating onset of M-phaseNature, 1990